Containing methicillin-resistant S aureus: Surveillance, control, and treatment methods

Postgraduate Medicine

Volumn 110, Issue 4, 2001, Pages 43-48

  Simor, Andrew E ^a,b,c  

^a Department of Microbiology ^*  (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AK TRACIN; BACITRACIN; BETA LACTAMASE; CEFALOTIN; CEFAZOLIN; CLOXACILLIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; LINEZOLID; METICILLIN; MINOCYCLINE; NAFCILLIN; PSEUDOMONIC ACID; RIFAMPICIN; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DRUG CHOICE; DRUG COST; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

EID: 0034797209     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2001.10.1043     Document Type: Conference Paper

References (22)

1. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: Microbiology, epidemiology, and preventive measures
2. Control of methicillinresistant Staphylococcus aureus at a university hospital: One decade later
3. Methicillin-resistant Staphylococcus aureus in nursing homes: Epidemiology, prevention, and management
4. Methicillin-resistant Staphylococcus aureus in US hospitals, 1975-1991
5. Methicillin-resistant Staphylococcus aureus in Europe
6. Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing?
7. Contrasting methicillin-resistant Staphylococcus aureus colonization in Veterans Affairs and community nursing homes
8. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk
9. Methicillin-resistant staphylococci: Genetics and mechanisms of resistance
10. Rapid and specific molecular identification of methicillin-resistant Staphylococcus aureus in endotracheal aspirates from mechanically ventilated patients
11. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus
12. Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus
13. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus
14. Mortality related to methicillin-resistant S aureus bacteremia compared to methicillin-sensitive S aureus bacteremia: A meta-analysis
15. Cost of nosocomial infection: Relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections
16. The economic impact of Staphylococcus aureus infection in New York City hospitals
17. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals
18. Emergence of vancomycin resistance in Staphylococcus aureus
19. Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management
20. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus
21. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: Is it cost effective?
22. Control of endemic methicillin-resistant Staphylococcus aureus: A cost-benefit analysis in an intensive care unit